IBT

International Biotechnology Trust Portfolio holdings

AUM $297M
1-Year Est. Return 17.25%
This Quarter Est. Return
1 Year Est. Return
+17.25%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$270M
AUM Growth
-$974K
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
70
New
Increased
Reduced
Closed

Top Buys

1
+$7.76M
2
+$7.74M
3
+$6.3M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$6.21M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$4.49M

Top Sells

1
+$8.6M
2
+$7.18M
3
+$5.83M
4
ACAD icon
Acadia Pharmaceuticals
ACAD
+$5.77M
5
WVE icon
Wave Life Sciences
WVE
+$5.63M

Sector Composition

1 Healthcare 98.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
51
$997K 0.37%
80,000
+25,420
52
$967K 0.36%
16,500
53
$889K 0.33%
788
54
$839K 0.31%
+70,000
55
$833K 0.31%
11,702
56
$788K 0.29%
20,000
+934
57
$743K 0.28%
31,723
-42,885
58
$730K 0.27%
58,600
59
$687K 0.25%
14,400
-78,600
60
$659K 0.24%
19,953
-70,000
61
$511K 0.19%
+56,000
62
$414K 0.15%
17,000
-88,829
63
$362K 0.13%
18,000
-190,000
64
$287K 0.11%
30,000
65
– –
-61,000
66
– –
-32,500
67
– –
-19,000
68
– –
-145,000
69
– –
-151,117
70
– –
-72,500
1 2
3